4-Hydroxy-4-(3-(4-pyridyl)propyl)piperidine → 2-(R)-(3-(S)-((4-Hydroxy-4-(3-(4-pyridyl)prop-1-yl)piperidin-1-yl)methyl)-4-(S)-phenylpyrrolidin-1-yl)-2-(cyclohexyl)acetic acid
Reaction equation
[CH:1]([C@@H:3]1[C@@H:7]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)[CH2:6][N:5]([C@H:14]([CH:25]2[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]2)[C:15]([O:17]CC2C=CC=CC=2)=[O:16])[CH2:4]1)=O.[OH:31][C:32]1([CH2:38][CH2:39][CH2:40][C:41]2[CH:46]=[CH:45][N:44]=[CH:43][CH:42]=2)[CH2:37][CH2:36][NH:35][CH2:34][CH2:33]1>>[OH:31][C:32]1([CH2:38][CH2:39][CH2:40][C:41]2[CH:46]=[CH:45][N:44]=[CH:43][CH:42]=2)[CH2:37][CH2:36][N:35]([CH2:1][C@@H:3]2[C@@H:7]([C:8]3[CH:9]=[CH:10][CH:11]=[CH:12][CH:13]=3)[CH2:6][N:5]([C@H:14]([CH:25]3[CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]3)[C:15]([OH:17])=[O:16])[CH2:4]2)[CH2:34][CH2:33]1Participants
3
Reactant 2
Product 1
Procedure
The title compound was prepared from 2-(R)-(3-(R)-formyl-4-(S)-phenylpyrrolidin-1-yl)-2-(cyclohexyl)acetic acid, benzyl ester (from EXAMPLE 1, Step I) and 4-hydroxy-4-(3-(4-pyridyl)propyl)piperidine.HCl (from EXAMPLE 81, Step A) using procedures analogous to those described in EXAMPLE 71, Steps A and B. For the title compound: 1H NMR (500 MHz) δ 1.00-4.00 (35H), 7.04 (d, J=5.7, 2H), 7.24-7.31 (5H), 8.40 (d, J=5.7, 2H); ESI-MS 520 (M+H).
Sources & evidence
- ORD record
- ord-ef4588e018db400689419260f2ab2d75
- Source dataset
- uspto-grants-2001_07
- Patent number
- US06265434B1
Reaction notes
Loading…